mechlorethamine has been researched along with (9R)-9-chloro-11,17-dihydroxy-17-(2-hydroxy-1-oxoethyl)-10,13,16-trimethyl-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-3-one in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bagot, M; Bernard, P; Beylot-Barry, M; Cordel, N; Courville, P; D'Incan, M; de Quatrebarbes, J; Delaunay, M; Estève, E; Joly, P; Souteyrand, P; Vaillant, L | 1 |
1 trial(s) available for mechlorethamine and (9R)-9-chloro-11,17-dihydroxy-17-(2-hydroxy-1-oxoethyl)-10,13,16-trimethyl-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-3-one
Article | Year |
---|---|
Treatment of early-stage mycosis fungoides with twice-weekly applications of mechlorethamine and topical corticosteroids: a prospective study.
Topics: Administration, Topical; Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Agents, Alkylating; Beclomethasone; Child; Drug Administration Schedule; Drug Therapy, Combination; Female; Glucocorticoids; Humans; Male; Mechlorethamine; Middle Aged; Mycosis Fungoides; Skin Neoplasms | 2005 |